BOHLIN GAREN G
SEC insider (Form 3/4/5 filer). CIK 0001254705. Director at Karyopharm Therapeutics Inc. (KPTI) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in STOUGHTON, MA.
Companies BOHLIN GAREN G has filed insider reports for
- Karyopharm Therapeutics Inc. (KPTI): Director
- COLLEGIUM PHARMACEUTICAL, INC (COLL): Director
BOHLIN GAREN G
CIK: 0001254705
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 21, 2026KPTI
Karyopharm Therapeutics Inc.
AwardDirect15.5K shares- - May 14, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
AwardDirect8.7K shares- - May 11, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
ExerciseDirect8.7K shares at avg. $16.49$143K - May 11, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
SaleDirect8.7K shares at avg. $37.18$323K - May 28, 2025KPTI
Karyopharm Therapeutics Inc.
AwardDirectNonstatutory Stock Option (right to buy)
4.6K shares- - May 15, 2025COLL
COLLEGIUM PHARMACEUTICAL, INC
AwardDirect9.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  KPTI Karyopharm Therapeutics Inc. | Award | 15,508 | - | $0 | Direct |
| May 14, 2026 |  COLL COLLEGIUM PHARMACEUTICAL, INC | Award | 8,741 | - | $0 | Direct |
| May 11, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Exercise | 8,700 | $16.49 | $143,463 | Direct |
| May 11, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Sale | 8,700 | $37.18 | $323,491 | Direct |
| May 28, 2025 | KPTI Karyopharm Therapeutics Inc. | Award Nonstatutory Stock Option (right to buy) | 4,600 | - | - | Direct |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award | 9,791 | - | - | Direct |
1-6 of 6 transactions